Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105543186A reveals novel biocatalytic route for high-purity chiral alcohols. Enables cost reduction in chiral alcohol manufacturing and supply chain reliability.
Patent CN105543186A enables high-purity chiral alcohol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN116904411A reveals mutant enzyme for efficient (R)-citronellal synthesis. Offers high ee value and conversion for reliable flavor and fragrance supplier needs.
Patent CN120843624A reveals high-efficiency biocatalytic synthesis. Achieves 99% conversion and ee value. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112538506A details a novel lipase-catalyzed route for Chloramphenicol Succinate, offering higher purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Patent CN114621986B reveals enzymatic synthesis for optically pure Taxol side chains. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN118126972A reveals acid-resistant carbonyl reductase mutant for efficient (S)-NBHP synthesis, offering significant cost reduction and supply chain reliability.
Patent CN118126972A reveals enhanced enzyme mutant for (S)-NBHP production offering superior acid resistance and reduced processing costs for pharmaceutical supply chains.
Patent CN114634957B reveals enzymatic synthesis for 4AA. Offers cost reduction and supply chain reliability for API manufacturing partners.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN102268398A reveals a novel nitrilase-based route for Iminodiacetic Acid. Discover cost reduction in glyphosate manufacturing and high-purity supply chain solutions.
Patent CN103255183B details enzymatic asymmetric reduction for high-purity intermediates. Offers significant cost reduction and supply chain reliability for statin synthesis.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN102925501A details a high-efficiency enzymatic route for statin intermediates, offering superior purity and scalable manufacturing capabilities for global supply chains.
Patent CN115948357A reveals novel ketoreductase mutants for eslicarbazepine production, offering superior stereoselectivity and cost-effective biocatalytic manufacturing solutions.
Patent CN103695486A reveals a novel one-pot enzymatic route for Atorvastatin intermediates, offering significant cost reduction and safer manufacturing for global API producers.
Novel biocatalytic route for sitagliptin intermediates offers high ee value and green manufacturing advantages for pharmaceutical supply chains globally.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.